You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high-grade endometrioid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Niraparib, Dostarlimab, Bevacizumab)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 2, 2022

Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +14 more
  • Biopsy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI

Not yet recruiting
  • Cytoreductive Surgery
  • +4 more
  • PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
  • Boston, Massachusetts
    Massachusetts General Hospital
May 21, 2022

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor Trial

Active, not recruiting
  • Fallopian Tube Endometrioid Tumor
  • +13 more
  • Orange, California
  • +19 more
Jan 10, 2023

Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

Recruiting
  • Platinum-Refractory Fallopian Tube Carcinoma
  • +11 more
  • Copanlisib Hydrochloride
  • +4 more
  • Aurora, Colorado
  • +2 more
Dec 8, 2022

Homologous Recombination Deficiency Among Newly Diagnosed,

Recruiting
  • Fallopian Tube Cancer
    • Arkhangelsk, Russian Federation
    • +24 more
    Jul 18, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

    Active, not recruiting
    • Ovarian Cancer
    • +9 more
    • Berlin, Germany
    • +14 more
    Mar 10, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated

    Recruiting
    • Ovarian Cancer
    • +3 more
    • ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
    • Blacktown, New South Wales, Australia
    • +5 more
    Nov 9, 2022

    Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United

    Active, not recruiting
    • Endometrial Clear Cell Adenocarcinoma
    • +4 more
    • Computed Tomography
    • +5 more
    • Houston, Texas
    • +6 more
    Dec 5, 2022

    Endometrial Cancer Trial (Megestrol Acetate)

    Recruiting
    • Endometrial Cancer
    • Megestrol Acetate
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences
    Nov 14, 2022

    Endometrioid Endometrial Cancer Trial (Narazaciclib, Letrozole 2.5mg)

    Not yet recruiting
    • Endometrioid Endometrial Cancer
    • (no location specified)
    Feb 1, 2023

    Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity Trial in Canada, United States (OLAPARIB)

    Completed
    Has Results
    • Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
    • Anchorage, Alaska
    • +46 more
    Mar 22, 2022

    Recurrent High Grade Uterine Cancer Trial in United States (Paclitaxel, Batiraxcept)

    Not yet recruiting
    • Recurrent High Grade Uterine Cancer
    • San Francisco, California
    • +3 more
    Apr 11, 2023

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Active, not recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +7 more
    • Anetumab Ravtansine
    • +2 more
    • Orange, California
    • +22 more
    Oct 22, 2022

    Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

    Recruiting
    • Platinum-resistant Ovarian Cancer
    • +6 more
    • olvimulogene nanivacirepvec
    • +3 more
    • Orlando, Florida
      AdventHealth Cancer Institute
    Sep 1, 2022

    Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

    Recruiting
    • Cervical Adenocarcinoma
    • +47 more
    • Bevacizumab
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Dec 5, 2022

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

    Terminated
    Has Results
    • Epithelial Ovarian Cancer
    • +4 more
    • Clovis, California
    • +4 more
    May 19, 2021

    Endometrial Carcinoma Trial (Lerociclib, Letrozole 2.5mg, Placebo)

    Not yet recruiting
    • Endometrial Carcinoma
    • (no location specified)
    Jan 26, 2023

    Investigate Adaptation and Evolution of Ovarian High-grade

    Recruiting
    • Ovarian Cancer
    • +6 more
      • Bristol, United Kingdom
      • +10 more
      Sep 8, 2022